Casdin Capital LLC

Casdin Capital LLC

Casdin Capital LLC

Overview
Date Founded

2011

Headquarters

1350 Avenue of the Americas,Suite 2405,New York, NY 10019-4801

Type of Company

Private

Employees (Worldwide)

14

Industries

Hedge Funds
Investment Services & Portfolio Management

Company Description

Casdin Capital focuses on investments in disruptive businesses and is positioned to capitalize off an underappreciated, disruptive technology shift currently unfolding in the life sciences and healthcare industry. They consider investment opportunities that span the entire healthcare continuum and into sectors such as agriculture, industrial manufacturing and traditional information technology.

Executives & Employees

Chief Compliance Officer & Chief Financial Officer

Chief Investment Officer

General Counsel

Chief Compliance Officer

Head Trader

Director of Research

Research Coordinator

Executive Coordinator

Research Coordinator

Administrative Director

Subscribe now to see full list of current and former executives
Paths to Casdin Capital LLC
Potential Connections via
Relationship Science
You
Casdin Capital LLC
Advisors & Consultants
Auditor

Ernst & Young LLP engages in the provision of assurance, tax, transactions, and advisory services. It offers audit, business risk, technology, security risk, and human capital services. The company was founded by Arthur Young and Alwin C. Ernst in 1989 and is headquartered in New York, NY.

Subscribe now to see advisors & consultants for over 2.5 million organizations
Subscribe now to see advisors & consultants for over 2.5 million organizations
Investments
Details Hidden

908 Devices, Inc. develops devices for chemical analysis. It develops its products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. The firm offers battery-operated, handheld, and chemical detection tools; and personal analyzers for biologists and chemists. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andy Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.

Details Hidden

Syros Pharmaceuticals, Inc. engages in the development of novel gene control therapies for cancer and other diseases. It has developed a proprietary platform that is designed to systematically and efficiently analyze unexploited region of DNA in human disease tissue to identify and drug novel targets linked to genomically defined patient populations. The company focuses on developing treatments for cancer and immune mediated diseases and is building a pipeline of gene control medicines. Syros Pharmaceuticals was founded by Richard A. Young, Nathanael S. Gray and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

Details Hidden

Flatiron Health, Inc. develops health care technology. Its OncologyCloud platform allows cancer centers, physicians and life science companies to gain actionable insights from clinical, practice management and billing data. The firm's software platform accelerates personalized medicine and research by applying advanced analytics to electronic patient care data documented by physicians. The company was founded by Nathaniel S. Turner and Zachary W. Weinberg in 2012 and is headquartered in New York, NY.

Subscribe now to see full investment details